National Oesophago-Gastric Cancer Audit: Annual report 2018
The 2018 Annual Report from the National Oesophago-Gastric (OG) Cancer Audit provides up-to-date information on the quality of OG cancer care provided by NHS organisations in England and Wales. Its results are a reflection of the dedication shown by staff at NHS trusts and Welsh local health boards, as well as the Audit team at NHS Digital and the Clinical Effectiveness Unit.
Sufficient time has now passed for the Audit to describe trends in patterns of care over a five-year period, between April 2012 and March 2017. During this time, many improvements have been demonstrated. Now, more patients with high-grade dysplasia (HGD) are receiving active treatment compared with five years ago. This report also documents the evolution of staging investigations, with an increased use of PET-CT scans among patients who are candidates for curative treatment. The Audit is also giving us a unique opportunity to see how outcomes have changed over time. Patients’ chances of surviving curative surgery have improved significantly over the last 10 years, although their risk of having a complication has not changed.
25/04/2019: This version 2 of the report includes revisions to the figure on average length of stay in hospital after curative surgery on p15 and p54, and figures on CT scanning for NHS trusts/ local health boards in Annex 8 (p78-80)
21/09/2018: In version 1.2, Figure 7.5 (p48) was updated to include the Welsh region. This was erroneously omitted from version 1.1